Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 262

1.

Glioblastoma-Derived IL6 Induces Immunosuppressive Peripheral Myeloid Cell PD-L1 and Promotes Tumor Growth.

Lamano JB, Lamano JB, Li YD, DiDomenico JD, Choy W, Veliceasa D, Oyon DE, Fakurnejad S, Ampie L, Kesavabhotla K, Kaur R, Kaur G, Biyashev D, Unruh DJ, Horbinski CM, James CD, Parsa AT, Bloch O.

Clin Cancer Res. 2019 Jun 15;25(12):3643-3657. doi: 10.1158/1078-0432.CCR-18-2402. Epub 2019 Mar 1.

PMID:
30824583
2.

In Reply: Factors Predicting Recurrence After Resection of Clival Chordoma Using Variable Surgical Approaches and Radiation Modalities.

Jahangiri A, Chin AT, Wagner JR, Kunwar S, Ames C, Chou D, Barani I, Parsa AT, McDermott MW, Benet A, El-Sayed IH, Aghi MK.

Neurosurgery. 2017 Aug 1;81(2):E32. doi: 10.1093/neuros/nyx137. No abstract available.

PMID:
28379552
3.

Autologous Heat Shock Protein Peptide Vaccination for Newly Diagnosed Glioblastoma: Impact of Peripheral PD-L1 Expression on Response to Therapy.

Bloch O, Lim M, Sughrue ME, Komotar RJ, Abrahams JM, O'Rourke DM, D'Ambrosio A, Bruce JN, Parsa AT.

Clin Cancer Res. 2017 Jul 15;23(14):3575-3584. doi: 10.1158/1078-0432.CCR-16-1369. Epub 2017 Feb 13.

4.

Safety and outcomes of preoperative embolization of intracranial hemangioblastomas: A systematic review.

Ampie L, Choy W, Lamano JB, Kesavabhotla K, Kaur R, Parsa AT, Bloch O.

Clin Neurol Neurosurg. 2016 Nov;150:143-151. doi: 10.1016/j.clineuro.2016.09.008. Epub 2016 Sep 19. Review.

PMID:
27668858
5.

Pleomorphic Xanthoastrocytoma with Anaplastic Features: Retrospective Case Series.

Rutkowski MJ, Oh T, Niflioglu GG, Safaee M, Tihan T, Parsa AT.

World Neurosurg. 2016 Nov;95:368-374. doi: 10.1016/j.wneu.2016.07.068. Epub 2016 Jul 28.

PMID:
27476694
6.

The limited capacity of malignant glioma-derived exosomes to suppress peripheral immune effectors.

Iorgulescu JB, Ivan ME, Safaee M, Parsa AT.

J Neuroimmunol. 2016 Jan 15;290:103-8. doi: 10.1016/j.jneuroim.2015.11.025. Epub 2015 Nov 28.

PMID:
26711578
7.

Immunomonitoring in glioma immunotherapy: current status and future perspectives.

Lamano JB, Ampie L, Choy W, Kesavabhotla K, DiDomenico JD, Oyon DE, Parsa AT, Bloch O.

J Neurooncol. 2016 Mar;127(1):1-13. doi: 10.1007/s11060-015-2018-4. Epub 2015 Dec 5. Review.

8.

Role of preoperative embolization for intradural spinal hemangioblastomas.

Ampie L, Choy W, Khanna R, Smith ZA, Dahdaleh NS, Parsa AT, Bloch O.

J Clin Neurosci. 2016 Feb;24:83-7. doi: 10.1016/j.jocn.2015.09.006. Epub 2015 Nov 12.

PMID:
26585384
9.

Erratum to: Predictors of recurrence in the management of chordoid meningioma.

Choy W, Ampie L, Lamano JB, Kesavabhotla K, Mao Q, Parsa AT, Bloch O.

J Neurooncol. 2016 Jan;126(1):117. doi: 10.1007/s11060-015-1963-2. No abstract available.

PMID:
26493739
10.

Predictors of recurrence in the management of chordoid meningioma.

Choy W, Ampie L, Lamano JB, Kesavabhotla K, Mao Q, Parsa AT, Bloch O.

J Neurooncol. 2016 Jan;126(1):107-116. doi: 10.1007/s11060-015-1940-9. Epub 2015 Sep 26. Review. Erratum in: J Neurooncol. 2015 Oct 22;:.

11.

Prognostic factors for recurrence and complications in the surgical management of primary chordoid gliomas: A systematic review of literature.

Ampie L, Choy W, Lamano JB, Kesavabhotla K, Mao Q, Parsa AT, Bloch O.

Clin Neurol Neurosurg. 2015 Nov;138:129-36. doi: 10.1016/j.clineuro.2015.08.011. Epub 2015 Aug 19. Review.

12.

The kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapy.

Zhai L, Dey M, Lauing KL, Gritsina G, Kaur R, Lukas RV, Nicholas MK, Rademaker AW, Dostal CR, McCusker RH, Raizer JJ, Parsa AT, Bloch O, Wainwright DA.

J Clin Neurosci. 2015 Dec;22(12):1964-8. doi: 10.1016/j.jocn.2015.06.018. Epub 2015 Aug 14.

13.

Association of tumor location, extent of resection, and neurofibromatosis status with clinical outcomes for 221 spinal nerve sheath tumors.

Safaee M, Parsa AT, Barbaro NM, Chou D, Mummaneni PV, Weinstein PR, Tihan T, Ames CP.

Neurosurg Focus. 2015 Aug;39(2):E5. doi: 10.3171/2015.5.FOCUS15183.

PMID:
26235022
14.

Surgery is cost-effective treatment for young patients with vestibular schwannomas: decision tree modeling of surgery, radiation, and observation.

Zygourakis CC, Oh T, Sun MZ, Barani I, Kahn JG, Parsa AT.

Neurosurg Focus. 2014 Nov;37(5):E8. doi: 10.3171/2014.8.FOCUS14435.

PMID:
26218621
15.

Heat shock protein vaccines against glioblastoma: from bench to bedside.

Ampie L, Choy W, Lamano JB, Fakurnejad S, Bloch O, Parsa AT.

J Neurooncol. 2015 Jul;123(3):441-8. doi: 10.1007/s11060-015-1837-7. Epub 2015 Jun 21. Review.

16.

Quality improvement in neurosurgery.

Rolston JD, Han SJ, Parsa AT.

Neurosurg Clin N Am. 2015 Apr;26(2):xiii-xiv. doi: 10.1016/j.nec.2015.01.001. Epub 2015 Feb 7. No abstract available.

PMID:
25771287
17.

Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma.

Sun MZ, Oh T, Ivan ME, Clark AJ, Safaee M, Sayegh ET, Kaur G, Parsa AT, Bloch O.

J Neurosurg. 2015 May;122(5):1144-50. doi: 10.3171/2014.9.JNS14193. Epub 2015 Mar 13.

PMID:
25768833
18.

Proportional upregulation of CD97 isoforms in glioblastoma and glioblastoma-derived brain tumor initiating cells.

Safaee M, Fakurnejad S, Bloch O, Clark AJ, Ivan ME, Sun MZ, Oh T, Phillips JJ, Parsa AT.

PLoS One. 2015 Feb 25;10(2):e0111532. doi: 10.1371/journal.pone.0111532. eCollection 2015.

19.

Impact of resident involvement in neurosurgery: an analysis of 8748 patients from the 2011 American College of Surgeons National Surgical Quality Improvement Program database.

Lim S, Parsa AT, Kim BD, Rosenow JM, Kim JY.

J Neurosurg. 2015 Apr;122(4):962-70. doi: 10.3171/2014.11.JNS1494. Epub 2015 Jan 23.

PMID:
25614947
20.

Factors predicting recurrence after resection of clival chordoma using variable surgical approaches and radiation modalities.

Jahangiri A, Chin AT, Wagner JR, Kunwar S, Ames C, Chou D, Barani I, Parsa AT, McDermott MW, Benet A, El-Sayed IH, Aghi MK.

Neurosurgery. 2015 Feb;76(2):179-85; discussion 185-6. doi: 10.1227/NEU.0000000000000611.

PMID:
25594191

Supplemental Content

Loading ...
Support Center